Teen-friendly therapy that works! The ATTEND programme uses mindfulness to help teens manage depression & strengthen family ...

Researchers have developed a mindfulness therapy tailored specifically to appeal to teenagers to help them cope with increasing levels of depression and mental health problems.

The FDA-approved schizophrenia and bipolar disorder therapy met the primary and secondary endpoint in a Phase III “withdrawal ...

Intra-Cellular Therapies' lumateperone shows significant efficacy in reducing schizophrenia relapse rates, with a 63% risk ...

In addition, new BrightView behavioral groups including anger management, coping skills and relapse prevention programs were shared with ... treatment and over 142,000 hours of counseling and therapy.

Discover a novel approach to reduce relapse rates for blood cancers treated via the revolutionary CAR T-cell therapy.